Coherus Biosciences | CHRS - Ebit

Aktienkurs
1.69
Täglich Wechseln
0.09 5.63%
Monatlich
2.42%
Jährlich
109.63%
Q1 Prognose
1.58




Ebit Veränderung Datum
AbbVie USD 5.81B 4.36B 2025-12
Acadia Pharmaceuticals USD 17.39M 18.36M 2025-12
Akebia Therapeutics USD -5.45M 9.4M 2025-12
ALKERMES USD -10.95M 100.03M 2025-12
Alnylam Pharmaceuticals USD 29.4M 59.36M 2025-12
Amarin USD -2.26M 564K 2025-12
Amgen USD 3.96B 464M 2025-12
Baxter International USD -214.2M 415.4M 2025-12
Biogen USD 659.6M 157M 2025-09
BioMarin Pharmaceutical USD 198.39M 230.08M 2025-12
Bristol-Myers Squibb USD 3.47B 567M 2025-12
Coherus Biosciences USD -39.08M 3.65M 2025-12
Eli Lilly USD 8.99B 1.57B 2025-12
Fujifilm JPY 89.96B 6.77B 2025-12
Gilead Sciences USD 2.96B 551M 2025-12
Ironwood Pharmaceuticals USD 33.22M 7.58M 2024-12
Merck USD 6.24B 1.32B 2025-12
Myriad Genetics USD -3M 20.3M 2025-12
Pacira USD 3.19M 9.96M 2025-12
Perrigo USD 84.4M 9M 2025-12
Pfizer USD 4.65B 71M 2025-12
PTC Therapeutics USD -81.62M 85.11M 2025-12
Regeneron Pharmaceuticals USD 898.6M 211.3M 2025-12
Sarepta Therapeutics USD -410.08M 347.2M 2025-12
Teva Pharmaceutical Industries USD 577M 491M 2025-12
Vertex Pharmaceuticals USD 1.26B 24.5M 2025-12
Xencor USD -53.63M 6.11M 2025-12
Zoetis USD 835M 140M 2025-12